Kaushik Thanki
Kaushik Thanki
Scientist, BioNTech RNA Pharmaceuticals
Dirección de correo verificada de biontech.de
Título
Citado por
Citado por
Año
Oral delivery of anticancer drugs: challenges and opportunities
K Thanki, RP Gangwal, AT Sangamwar, S Jain
Journal of controlled release 170 (1), 15-40, 2013
3682013
Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: Implications on oral bioavailability, antitumor efficacy and drug induced toxicity
AK Jain, K Thanki, S Jain
Molecular Pharmaceutics 10 (9), 3459-3474, 2013
1642013
Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel
S Jain, D Kumar, NK Swarnakar, K Thanki
Biomaterials, 2012
1532012
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration
AK Agrawal, H Harde, K Thanki, S Jain
Biomacromolecules 15 (1), 350-360, 2014
1242014
Gelatin Coated Hybrid Lipid Nanoparticles for Oral Delivery of Amphotericin B
S Jain, PU Valvi, NK Swarnakar, K Thanki
Molecular Pharmaceutics, 2012
1132012
Dissolution improvement of simvastatin by surface solid dispersion technology
M Rao, Y Mandage, K Thanki, S Bhise
Dissolution technologies 17 (2), 27-34, 2010
932010
Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: Implications on drug induced cardiotoxicity and nephrotoxicity
S Jain, AK Jain, M Pohekar, K Thanki
Free Radical Biology and Medicine, 2013
902013
Solidified Self-Nanoemulsifying Formulation for Oral Delivery of Combinatorial Therapeutic Regimen: Part I. Formulation Development, Statistical Optimization, and In Vitro …
AK Jain, K Thanki, S Jain
Pharm Res 31 (4), 923-945, 2014
622014
Positively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: systematic development, in vitro, ex vivo and in vivo evaluation
S Beg, G Sharma, K Thanki, S Jain, OP Katare, B Singh
International journal of pharmaceutics 493 (1-2), 466-482, 2015
612015
Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity
NK Swarnakar, K Thanki, S Jain
Pharmaceutical research 31 (5), 1219-1238, 2014
572014
Development and in vitro evaluation of floating rosiglitazone maleate microspheres
MRP Rao, SG Borate, KC Thanki, AA Ranpise, GN Parikh
Drug development and Industrial pharmacy 35 (7), 834-842, 2009
542009
Enhanced antitumor efficacy and reduced toxicity of docetaxel loaded estradiol functionalized stealth polymeric nanoparticles
S Jain, G Spandana, AK Agrawal, V Kushwah, K Thanki
Molecular pharmaceutics 12 (11), 3871-3884, 2015
512015
Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using Doxorubicin-and Coenzyme Q10-liquid crystalline nanoparticles in comparison …
NK Swarnakar, K Thanki, S Jain
Nanomedicine: Nanotechnology, Biology and Medicine 10 (6), 1231-1241, 2014
492014
Oral bioavailability and pharmacodynamic activity of hesperetin nanocrystals generated using a novel bottom-up technology
G Shete, YB Pawar, K Thanki, S Jain, AK Bansal
Molecular pharmaceutics 12 (4), 1158-1170, 2015
352015
Novel self-nanoemulsifying formulation of quercetin: implications of pro-oxidant activity on the anticancer efficacy
AK Jain, K Thanki, S Jain
Nanomedicine: Nanotechnology, Biology and Medicine 10 (5), e959-e969, 2014
352014
Combinatorial bio-conjugation of gemcitabine and curcumin enables dual drug delivery with synergistic anticancer efficacy and reduced toxicity
S Jain, R Jain, M Das, AK Agrawal, K Thanki, V Kushwah
RSC Advances 4 (55), 29193-29201, 2014
322014
Engineering of small interfering RNA-loaded lipidoid-poly (DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design …
K Thanki, X Zeng, S Justesen, S Tejlmann, E Falkenberg, ...
European journal of pharmaceutics and biopharmaceutics 120, 22-33, 2017
312017
Systematic development of novel cationic self-nanoemulsifying drug delivery systems of candesartan cilexetil with enhanced biopharmaceutical performance
G Sharma, S Beg, K Thanki, OP Katare, S Jain, K Kohli, B Singh
RSC Advances 5 (87), 71500-71513, 2015
312015
Macromolecular bipill of gemcitabine and methotrexate facilitates tumor-specific dual drug therapy with higher benefit-to-risk ratio
M Das, R Jain, AK Agrawal, K Thanki, S Jain
Bioconjugate chemistry 25 (3), 501-509, 2014
292014
Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: Part II in vivo pharmacokinetics, antitumor efficacy and hepatotoxicity
AK Jain, K Thanki, S Jain
Pharm Res 31 (4), 946-958, 2014
292014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20